World of DTC Marketing
AUGUST 10, 2022
CPG marketers are trying to maintain market share amid price increases and smaller product sizes, leading to a more significant jump in consumerism. But, in pharma marketing, the changes affect every product category. Consumers share more information online than ever as inflation cuts into their disposable income. I’ve seen posts on everything from opinions on detergents to the best and more inexpensive ice cream.
MedCity News
AUGUST 10, 2022
UNC Health recently partnered with Gozio Health and WELL Health to add new features to its app. Patients can now download the app via a link sent in appointment reminder texts, view a map of immediate care options near them and access appointment wayfinding via their mobile phone calendar.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmExec
AUGUST 10, 2022
Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting. What is being done to smooth the path for pricing and reimbursement?
MedCity News
AUGUST 10, 2022
Vector BioPharma has launched from the biotech startup incubator of Versant Ventures, which is backing the company with a $30 million Series A financing. Vector is developing virus-like particles with the capability to deliver large payloads of genetic medicines to a wide range of tissues.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmExec
AUGUST 10, 2022
Marie-France Tschudin, president, innovative medicines international, and chief commercial officer at Novartis, taps into life lessons to help bring therapies to people in novel ways.
PharmaVoice
AUGUST 10, 2022
Miruna Sasu is on a mission to use real world data to help wipe out cancer. She believes this audacious goal is within reach, and as president and CEO of COTA, she is inspiring her team to create a “path to care” for oncology patients.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Nixon Gwilt Law
AUGUST 10, 2022
TLDR: If you want to incentivize patient adherence to a medication adherence or substance use disorder (“ SUD ”) treatment program without running afoul of the Anti-kickback Statute (“ AKS ”) or Civil Monetary Penalties law (“ CMP ”), a recent advisory opinion indicates that evidence-based, clinically relevant incentives may be the key. Now let’s get to the details.
MedCity News
AUGUST 10, 2022
By placing the power to detect atrial fibrillation into the hands of 6 billion global smartphone users, validation of further physiological parameters will be expedited and the subsequent adoption of this technology into DTx will enable the low-cost tools required to remove barriers to care and improve heart health across the globe.
Pharmaceutical Commerce
AUGUST 10, 2022
Recognizing the sustainability issue is an important step, but the biopharmaceutical sector encompasses a complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.
MedCity News
AUGUST 10, 2022
At the beginning of the pandemic, we were celebrated as heroes. Now the heroes are asking for help in addressing this new phenomenon of empathy fatigue. If we fail to ignore this crisis of compassion, patients and clinicians will continue to suffer.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Map My Customers
AUGUST 10, 2022
Why are successful businesses willing to put so much money into mobile sales enablement tools? Because they know it works — according to statistics from G2’s LearnHub , 76% of organizations see an increase in sales between 6% to 20% due to the use of sales enablement tools. Effective sales enablement means that you’re arming your sales reps with everything they need to get ahead, be prepared, and feel confident, informed, and capable.
MedCity News
AUGUST 10, 2022
In a recent webinar, Carta Healthcare CEO Matt Hollingsworth shared how his health tech business is using AI for data mining in healthcare to transform the patient experience.
Pharmaceutical Technology
AUGUST 10, 2022
Cerevance has entered a multi-year strategic research partnership with Merck (MSD outside North America) to discover new targets for Alzheimer’s disease. Under the alliance, the companies will use the Nuclear Enriched Transcript Sort sequencing (NETSseq) technology platform of Cerevance to identify the targets. Furthermore, Cerevance will simultaneously out-license a discovery-stage programme to Merck under the partnership.
MedCity News
AUGUST 10, 2022
Monkeypox was declared a public health emergency last week, but many healthcare professionals feel confused about how to best prepare for a potential outbreak in their area. While they wait for clearer guidance from the CDC and their local health departments, there are key actions they can take, such as decreasing stigma about the disease and advocating for increased access to vaccines, tests and treatments.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
European Pharmaceutical Review
AUGUST 10, 2022
In order to meet microbiological quality standards, herbal medicine pills are often irradiated at the primary package or final product stage. Radiation is chosen over thermal terminal sterilisation to minimise decomposition of crude drug components, volatilisation of essential oils and changes in colour. However, with limited evidence on the impact ionising radiation has on the constituents of such products, researchers set out to investigate whether irradiation impacts drug quality beyond micro
MedCity News
AUGUST 10, 2022
Nearly 25% of working-age adults have hearing issues. Yet 50% of people with untreated hearing loss have never had their hearing professionally checked before the age of 60, and 60% of people with hearing loss are below retirement age. Tuned is trying to change that by offering its platform to employers as a benefit.
European Pharmaceutical Review
AUGUST 10, 2022
Gilead Sciences has signed a definitive agreement to acquire outstanding share capital of clinical-stage biotechnology company MiroBio for around $405 million. The deal includes MiroBio’s proprietary I-ReSToRE ( RE ceptor S election and T argeting t o R einstate immune E quilibrium) discovery platform and its entire portfolio of immune inhibitory receptor agonists.
MedCity News
AUGUST 10, 2022
If the 12 states that have not expanded Medicaid did so, the uninsured rate would drop by 29.1%, the report found. The populations that would benefit the most would be Black Americans, young adults and women of reproductive age.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmExec
AUGUST 10, 2022
The technology is not just about digital enablement anymore.
MedCity News
AUGUST 10, 2022
Bristol Myers Squibb has data showing that its multiple myeloma treatment Abecma beat the standard of care, preliminary Phase 3 results that could support moving the FDA-approved CAR T-cell therapy into an earlier line of treatment—ahead of a rival cell therapy. In other BMS cell therapy news, the pharma giant started an R&D alliance focused on inflammatory bowel disease.
PharmExec
AUGUST 10, 2022
Failed efforts do not overshadow field’s progress, resolve.
European Pharmaceutical Review
AUGUST 10, 2022
Amgen has entered into a definitive agreement to acquire ChemoCentryx Inc., a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Under the agreement, ChemoCentryx will be acquired for $52 per share in cash, for a total enterprise value of approximately $3.7 billion. “The acquisition of ChemoCentryx represents a compelling opportunity for Amgen to add to our decades-long leadership in inflammation and nephro
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmaTimes
AUGUST 10, 2022
Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the UK
PharmExec
AUGUST 10, 2022
How one company in particular has adjusted its internal and customer-facing strategies in compliance training amid today’s heightened business-risk climate.
Pharmaceutical Technology
AUGUST 10, 2022
Catale n t has signed an agreement for the acquisition of full-service specialty Contract Development and Manufacturing Organization (CDMO) Metrics Contract Services for $475m from Mayne Pharma. The takeover of Metrics will bolster the expertise of Catalent in the development of integrated oral solid formulation, production and packaging to aid customers in streamlining and expediting their programmes.
PharmExec
AUGUST 10, 2022
Major stakeholders—including policymakers, public-private interests, and academia—are increasingly embracing the potential of proteomics technology in reshaping diagnostics and patient care.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Vodori
AUGUST 10, 2022
Every life science organization has a slightly different content review and approval process to ensure their materials are accurate, compliant , and on-brand. Communicating clearly during the review process–such as indicating the difference between suggested vs. mandatory revisions or edits–is essential to ensuring your documents meet all internal and external requirements. .
PharmExec
AUGUST 10, 2022
Innovative and continuous remote patient monitoring, along with AI-based predictive analytics, are advancing progress toward replacing the one-size-fits-all, population-driven vaccination model.
Pharmaceutical Technology
AUGUST 10, 2022
North America extended its dominance for artificial intelligence (AI) hiring among pharmaceutical industry companies in the three months ending June. The number of roles in North America made up 53.2% of total AI jobs - up from 47.6% in the same quarter last year. That was followed by Asia-Pacific, which saw a 0.9 year-on-year percentage point change in AI roles.
PharmExec
AUGUST 10, 2022
The BCG Market Access Roundtable outlines the new and advanced access competencies required to enable functional operationalization and delivery of this critical role in biopharma—today a key strategic partner in achieving overall business goals.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
252 
Let's personalize your content